Translational Neuroscience (Dec 2023)

Preoperatively administered single dose of dexketoprofen decreases pain intensity on the first 5 days after craniotomy: A single-centre placebo-controlled, randomized trial

  • Simon Éva,
  • Csipkés Csaba,
  • Andráskó Dániel,
  • Kovács Veronika,
  • Szabó-Maák Zoltán,
  • Tankó Béla,
  • Buchholcz Gyula,
  • Fülesdi Béla,
  • Molnár Csilla

DOI
https://doi.org/10.1515/tnsci-2022-0323
Journal volume & issue
Vol. 14, no. 1
pp. p. 1 – 211

Abstract

Read online

Headache attributed to craniotomy is an underestimated and under-treated condition. Previous studies confirmed the efficacy of preemptive analgesia with non-steroidal anti-inflammatory agents. The aim of the present work was to test the hypothesis of whether a single preoperatively administered dose of dexketoprofen (DEX) has the potency to decrease postcraniotomy headache (PCH) as compared to placebo (PL).

Keywords